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ABSTRACT
Retroviruses rely on host RNA-binding proteins to
modulate various steps in their replication.
Previously several animal retroviruses were
determined to mediate Dhx9/RNA helicase A (RHA)
interaction with a 50 terminal post-transcriptional
control element (PCE) for efficient translation.
Herein PCE reporter assays determined HTLV-1
and HIV-1 RU5 confer orientation-dependent PCE
activity. The effect of Dhx9/RHA down-regulation
and rescue with siRNA-resistant RHA on expres-
sion of HIV-1
NL4–3 provirus determined that RHA
is necessary for efficient HIV-1 RNA translation
and requires ATPase-dependent helicase function.
Quantitative analysis determined HIV-1 RNA
steady-state and cytoplasmic accumulation were
not reduced; rather the translational activity of
viral RNA was reduced. Western blotting deter-
mined that RHA-deficient virions assemble with
Lys-tRNA synthetase, exhibit processed reverse
transcriptase and contain similar level of viral
RNA, but they are poorly infectious on primary
lymphocytes and HeLa cells. The results demon-
strate RHA is an important host factor within
the virus-producer cell and within the viral
particle. The identification of RHA-dependent
PCE activity in cellular junD RNA and in six of
seven genera of Retroviridae suggests conserva-
tion of this translational control mechanism
among vertebrates, and convergent evolution of
Retroviridae to utilize this host mechanism.
INTRODUCTION
Retroviruses rely on host RNA-binding proteins to
modulate post-transcriptional control of viral gene expres-
sion. Several animal retroviruses contain a RNA struc-
tural element within their 50 untranslated region (UTR)
that is necessary for eﬃcient viral protein synthesis (1).
Viral proteins are not required. Instead this retroviral
post-transcriptional control element (PCE) requires inter-
action with host Dhx9/RNA helicase A (RHA) (2). PCE
was originally identiﬁed in the 50 long terminal repeat
(LTR) of avian spleen necrosis virus (3) and subsequently
in retroviruses that infect feline, bovine, catarrhine, and
human hosts (4–6). These viruses represent ﬁve genera of
the Retroviridae (alpharetrovirus, betaretrovirus, delta-
retrovirus, gammaretrovirus and spumavirus). The possi-
bility of PCE activity in the lentivirus genus was addressed
in this study.
RHA recognizes functionally redundant structural
features encoded by the RU5 regions of the SNV LTR
(2,7). Experiments with human T-cell leukemia type 1
(HTLV-1)provirusdeterminedthatRHAdown-regulation
reduces the polysome association of HTLV-1 gag RNA
and severely attenuates virion production, indicating that
RHA is an important host factor for HTLV-1 replication
(5). Reporter assays determined the HTLV-1 LTR is suﬃ-
cientforPCEactivityalthoughasuﬃcientrolefortheRU5
regions remains to be evaluated. Subsequent to identiﬁca-
tion in Retroviridae, PCE activity was identiﬁed in the
complex 50 UTR of rat and human junD (2). RHA is nec-
essary for eﬃcient translation of endogenous junD and
results in the reporter assay demonstrated that RHA
down-regulation eliminates junD PCE activity (2).
Recently RHA/Dhx9 was identiﬁed as an important
host factor in HIV-1 replication in meta-analysis of
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studies detected increased HIV-1 gene expression as
measured by HIV-1 LTR-luciferase reporter gene
activity (9); an eﬀect on balanced expression of the
unspliced HIV-1 gag RNA; and increased virion protein
production (10). The results suggested RHA aﬀects HIV-1
transcription and/or post-transcriptional expression.
Biochemical analysis has revealed that RHA can act as a
scaﬀold to bridge the association of CREB-binding
protein and RNA polymerase II (11). And a role for inter-
action with HIV-1 RNA was invoked from Northwestern
analysis detecting RHA interaction with the HIV-1 trans-
activation response element (TAR) within the R region of
the HIV-1 50 LTR (9); TAR is the target for the essential
HIV-1 Tat transcriptional trans-activator. Recently,
Liang and colleagues determined that RHA interacts
with HIV-1 Gag and is packaged into HIV-1 particles in
an RNA-dependent manner. RHA down-regulation by
siRNA decreased HIV-1 infectivity that was attributed
in part to lower reverse transcriptase (RT) activity (12).
In summary, RHA appears to inﬂuence HIV-1 gene
expression and possibly the process of virus assembly. A
possible role for RHA in translation of the virus and
possible involvement of the ATP-dependent helicase
activity remains an open issue.
Given the identiﬁcation of RHA-dependent PCE
activity in the RU5 of several animal retroviruses, we
evaluated the RU5 regions of human retroviruses,
HTLV-1 and HIV-1, for PCE reporter activity. We also
examined the eﬀect of RHA down-regulation and rescue
with siRNA-resistant RHA on expression of HIV-1
provirus, virion production, content and infectivity in
PBMC. The results demonstrated that RU5 of HIV-1
and HTLV-1 confer orientation-dependent PCE reporter
activity, and that RHA aﬀects two steps in replication of
HIV-1: (i) translation of the viral RNA and (ii) infectivity
of progeny virions.
MATERIALS AND METHODS
Cell culture, transfection, infection
HEK 293 and HeLa TZM-bl (13–16) were cultured in
Dulbecco’s modiﬁed eagle medium (Invitrogen), 10%
FBS (Invitrogen) and 1% antibiotic (Gibco) at 37 C/5%
CO2. Peripheral blood mononuclear cells (PBMCs) were
isolated as described previously (17) and were stimulated
by 5mg/ml PHA and 100U/ml recombinant human
Interleukin-2 (Roche) for 2 days in RPMI 1640 medium
(Invitrogen), 10% FBS, 1% antibiotic and then with
supplementation of 50U/ml Interleukin-2 at 37 C/5%
CO2.
Cultures of 2.5 10
5 HEK 293 cells per 35mm dish
were incubated overnight in 2ml medium and then
transfected with 2mg indicated reporter plasmid, 150ng
pGL3 ﬁreﬂy luciferase plasmid in 2 HBS as described
(3) for 2 days. Cells were harvested in PBS, resuspended
in 50ml NP40 lysis buﬀer and 5ml lysate was tested for
Luciferase activity (Promega) as described (18) or
diluted for HIV-1 Gag p24 ELISA (Zeptometrix).
Construction of PCE reporter plasmids is provided in
Supplementary Data. HTLV-1 reporters contain the
Tax-dependent U3 reporter and were co-transfected with
500ng HTLV-1 tax-1 expression plasmid. Methods for
RNA isolation and analysis are provided in
Supplementary Data.
For siRNA transfection, 1 10
6 HEK 293 cells per
10cm dish were cultured overnight and treated with
50ml Oligofectamine (Invitrogen) and 20mM indicated
siRNA (Dharmacon) in 2ml OptiMEM media (Gibco)
and 5ml DMEM without serum. Previously described
(2) RHA siRNA: RHA1 UAGAAUGGGUGGAGAAG
AAUU and RHA2 GGCUAUAUCCAUCGAAAU
UUU and non-silencing scrambled (Sc) siRNA UAGAC
UAGCUGACGAGAAAUU were transfected for 4h,
and the cultures were supplemented with 3.5ml DMEM
containing 30% FBS, 1% antibiotic and incubated for
48h. These cells were split, cultured overnight. After
second siRNA treatment, cells were cotransfected with
10mg pNL101 HIV-1
NL4–3 and 5mg siRNA-resistant
FLAG-tagged RHA (FL-RHA) or 5mg siRNA-resistant
FL-RHA in 1:3 DNA to FuGene6 (Roche) ratio by man-
ufacturer protocol. RHA down-regulation was veriﬁed by
immunoblot as described in Supplementary Data and ref.
(2).
For infection experiments, HIV-1
NL4–3 was propagated
by transfection of cultures of 1 10
6 HEK 293 cells per
10cm dish with 10mg pNL101 in FuGene6 for 48h.
Virus-containing cell-free supernatant was used for
Gag p24 ELISA, and 2ng HIV-1 p24 was used to infect
1 10
6 PBMC or 2 10
5 HeLa TZM-bl cells (13–16). As
described previously (19), virus growth on PBMC target
cells was monitored by Gag ELISA on cell-free
supernatant. HeLa TZM-bl cultures were harvested 48h
post-infection, extracted in the NP40 lysis buﬀer, 10mg
aliquots determined by Bradford assay, and used for
Luciferase assay.
Statistical analyses
Four independent PCE reporter transfections were per-
formed and data were log-transformed for the statistical
analyses. ANOVA model was used to study the diﬀerences
in Gag protein level and gag RNA level. Dunnett’s method
was used to adjust for multiple comparisons. Data are pre-
sented as mean fold change with corresponding P-values
(Figures 1 and 2). A one sample t-test compared the fold
change diﬀerences in HIV-1 Gag production between
RHAi and Sci groups (Figure 4). Three replicates were
obtained for the HIV-1 infection assays. Data were
analyzed using an ANOVA model that included group,
time and their interaction term. Holm’s method was used
to adjust for multiplicity (Figures 3 and 8).
RESULTS
HTLV-1 RU5 provide orientation-dependent PCE activity
Previous results demonstrated that the 50 LTR of
HTLV-1
ACH confers PCE activity in reporter assays (5).
PCE reporter activity is deﬁned by Rev/Rev responsive
element (RRE)-independent expression of intron-
containing HIV-1 gag RNA (3–5). Site-directed
Nucleic Acids Research,2010, Vol.38, No. 5 1687mutagenesis of SNV RU5 have determined that two func-
tionally redundant stem-loop structures encoded by RU5
provide orientation-dependent PCE activity (5,6). To
determine whether the R and U5 regions of HTLV-1 are
necessary or suﬃcient for PCE activity, PCE reporter
plasmids were generated (Supplementary Data) that
contain the HTLV-1 U3 promoter and lack or contain
R (nucleotides 1–220, relative to the transcription start
site) and U5 (nucleotides 237–402) in the sense and
antisense orientations (Figure 1A). The plasmids were
cotransfected with tax-1 transcriptional trans-activator
of the HTLV-1 U3 promoter. HIV-1 Gag levels were
measured by ELISA. Results of four independent
transfection experiments were evaluated for statistical
trends (Figure 1A). Compared to pHTLV-1 that
lacks RU5, pHTLV-1RU5 exhibited low but detectable
Figure 1. HTLV-1 RU5 is necessary for PCE activity and interaction with RHA. (A) Drawing of HTLV-1 PCE-gag reporter plasmid with
HTLV-1R depicted in blue and U5 in purple with corresponding sequence shown below. Arrow indicates transcription start site; 50 ss, splice
site; pA(n), polyadenylation signal. Dashed line denotes deletion of RU5 and reverse arrow indicates antisense orientation (AS) of RU5. HEK 293
cells were transfected with indicated reporter plasmid and HTLV-1 tax-1 expression plasmid to trans-activate the HTLV-1 U3 promoter for 48h.
Gag protein production was measured by Gag p24 ELISA and gag mRNA was quantiﬁed by RT-real-time PCR in four independent experiments.
ANOVA model was used to study the diﬀerences in Gag protein level and gag RNA level and data are presented as mean fold change with
corresponding P-values relative to pHTLV-1 with P-value indicated in parentheses. Asterisks indicate statistically signiﬁcant diﬀerence (P 0.05).
(B) RNA aﬃnity chromatography was performed with HeLa nuclear extract and equimolar HTLV-1 RU5, RU5 AS, R, U5 or c-myc RNA bait.
After sequential washes with KCl, high aﬃnity proteins were eluted in 2M KCl and immunoblotted with RHA antiserum lanes: input lysate; M,
marker; Beads, reaction with no RNA control and indicated RNA bait.
1688 Nucleic Acids Research, 2010, Vol.38, No. 5Rev/RRE-independent expression of HIV-1 gag RNA.
Gag levels increased 2-fold in response to RU5 in the
sense but not the antisense orientation (pHTLV-1RU5,
P=0.03 and pHTLV-1AS, P=0.22). HTLV-1R in
either the sense or antisense orientation did not increase
Gag production. HTLV-1 U5 was inhibitory to Gag
protein production in either sense (P=0.01) or antisense
orientation (P 0.01) orientation, which may be attribut-
able to RNA structural features that impede ribosome
scanning (20,21). To examine the abundance of
steady-state gag RNA, polyA+ RNA was prepared
from these samples; reverse transcribed and subjected to
real-time PCR with gag and  -actin primers. Signiﬁcant
diﬀerences in gag mRNA levels were not observed among
the samples, indicating the increase in Gag production is
not attributable to increased mRNA accumulation
(Figure 1A). The results indicated that HTLV-1R or U5
are not suﬃcient for PCE activity and the combination of
R and U5 function in an orientation-dependent manner to
provide HTLV-1 PCE reporter activity.
Association with RHA was evaluated by RNA aﬃnity
chromatography and immunoblot by the protocol used to
identify speciﬁc interaction of RHA with SNV PCE (2).
Biotinylated HTLV-1 RU5, R and U5 transcripts or
c-myc control RNA were synthesized with T7 RNA
polymerase and puriﬁed on G-25 columns. Equimolar
amounts (15mM) of each transcript were bound to
streptavidin agarose beads, incubated with HeLa nuclear
lysate, and washed with binding buﬀer. Low aﬃnity
RNA-binding proteins were eluted by progressive treat-
ment with elution buﬀer with 40, 100 and 200mM KCl.
High aﬃnity RNA-binding proteins were eluted in 2M
KCl and immunoblotted with antisera to RHA
(Figure 1B). RHA co-precipitated with HTLV-1 RU5.
RHA was less abundant in reactions with equimolar
amounts of R or U5, which correlated with the dearth
of PCE activity. RHA was not enriched on beads alone,
antisense RU5 (AS-RU5) or c-myc 50 UTR RNA,
indicating that RHA interaction with RU5 was not attrib-
utable to non-speciﬁc interaction.
HIV-1 RU5 confer PCE activity
A similar approach was used to examine HIV-1 RU5 for
PCE activity. As summarized in Figure 2A, PCE reporter
plasmids that encode the SNV U3 promoter and HIV-1
leader and gag open reading frame were evaluated in four
independent transfections. Baseline Gag production was
observed from pHIV-1U5 that lacks R and
pHIV-1RU5AS that contains RU5 in the antisense orien-
tation did not change Gag production (P=1). The
pHIV-1RU5 that contains RU5 in the sense orientation
exhibited Rev/RRE-independent Gag production at a
level 3.5-fold greater than baseline (pHIV-1RU5,
P=0.005). A similar level of PCE activity is observed
from SNV PCE reporter pYW100 that contains SNV
RU5 (4.9-fold). RT-real-time PCR determined steady-
state gag RNA levels were similar among the samples
(Figure 2A), indicating the increase in Gag production is
not attributable to increased accumulation of the mRNA.
RNA aﬃnity chromatography and RHA immunoblot
surveyed association of HIV-1 RU5 with RHA. RHA
co-precipitated with HIV-1 RU5 but was less abundant
in equimolar HIV-1R or U5 (Figure 2B). RHA was not
enriched in reactions with beads alone or c-myc RNA,
indicating that RHA interaction with RU5 was not attrib-
utable to non-speciﬁc interaction. To examine physical
interaction in cells, in addition, RNA co-IP assays were
performed on cells co-transfected with pHIV-1 RU5 and
pCMV-FL-RHA or empty pFL plasmid. Cytoplasm was
harvested in aliquots for IP with FLAG antibody fol-
lowed by RNA isolation from the immunoprecipates,
or isolation of cytoplasmic RNA. RNA from the
immunoprecipates was treated with random hexamers in
reactions with RT and without RT, and reactions with
primers speciﬁc for gag or junD control were subjected
to real-time PCR (2). The copy number of gag in the
cytoplasmic RNA was similar between samples with
FL-RHA or empty FL (2.7 10
5 and 3.9 10
5, respec-
tively). The gag copy number in FL-RHA co-precipitate
(3.5 10
4) was enriched >3-fold over the empty FL
control, which provided the detection limit of the assay
(1.0 10
4). In sum, the RNA co-precipitation results agree
with the RNA aﬃnity chromatography and further dem-
onstrate that gag RNA interacts with RHA in vivo.W e
conclude that HIV-1 U5 is not suﬃcient for PCE activity
and RU5 function in an orientation-dependent manner to
provide PCE reporter activity.
RHA modulates the cytoplasmic utilization of
HIV-1 gag RNA
To evaluate whether RHA is necessary for eﬃcient trans-
lation of HIV-1, RHA was down-regulated with two
previously characterized siRNAs or non-silencing
scrambled control siRNA (Sc) for 48h (2) (data not
shown). These cells were transfected with HIV-1
NL4–3
and the same siRNA for 48h and immunoblot veriﬁed
RHA down-regulation (Figure 3A). Total cellular
protein was subjected to Gag immunoblot and cell-free
supernatant medium was subjected to Gag ELISA. The
results indicate signiﬁcant reductions in cell-associated
(P=0.0006) and cell-free Gag (P<0.0001; Figure 3B).
The equivalent reductions in cell-associated and cell-free
Gag indicated that RHA down-regulation aﬀects the
rate of Gag expression, but does not impair particle
assembly or release. ELISAs were also performed on
cell-free supernatant collected sequentially over 48h.
These results also indicated that RHA down-regulation
delayed the onset of virion production by twelve hours
and reduced absolute Gag production (Figure 3C).
Metabolic labeling measured the eﬀect of RHA
down-regulation on Gag protein synthesis. After 1h incu-
bation with [
35S]-cysteine/methionine, IP was performed
with Gag or b-Actin antibody. As shown in Figure 4,
RHA down-regulation signiﬁcantly reduced de novo Gag
protein synthesis, but did not reduce b-Actin protein syn-
thesis (P=0.002). To quantify the eﬀect of RHA
down-regulation on steady-state gag RNA abundance
and cytoplasmic accumulation, nuclear and cytoplasmic
RNA were isolated and subjected to RT-real-time PCR.
Nucleic Acids Research,2010, Vol.38, No. 5 1689Figure 2. HIV-1 RU5 is necessary for PCE activity and interaction with RHA. (A) Drawing of HIV-1 PCE-gag reporter plasmid with HIV-1R
depicted in green and U5 in orange with corresponding sequence shown below. Arrow indicates transcription start site; 50 ss, splice site; pA(n),
polyadenylation signal. Dashed line denotes deletion of R and reverse arrow indicates antisense orientation (AS) of RU5. HEK 293 cells were
transfected with the indicated plasmid, Gag production was measured by Gag p24 ELISA and gag mRNA was quantiﬁed by RT-real-time PCR.
ANOVA model was used to study the diﬀerences in Gag protein level and gag RNA level. Data are presented as mean fold change with corre-
sponding P-values. Results are presented as mean fold change relative to pHIV-1U5 with P-value indicated in parentheses. Asterisks indicate
statistically signiﬁcant diﬀerence (P 0.05). (B) RNA aﬃnity chromatography was performed with HeLa nuclear extract and equal moles of
indicated HIV-1 RNA or c-myc RNA bait. High aﬃnity proteins were eluted in 2M KCl and immunoblotted with RHA antiserum. Lanes:
input lysate; M, marker; Beads, reaction with no RNA control and indicated RNA bait.
Figure 3. RHA is necessary for eﬃcient production of HIV-1 Gag. HEK 293 cells were transfected consecutively with non-silencing (Sc) or RHA
siRNAs (RHA) and HIV-1
NL4–3.( A) Immunoblot of total cell protein with antiserum to RHA or a-Tubulin veriﬁed RHA down-regulation.
(B) Cell-associated (n=5) and cell-free (n=16) Gag levels measured by Gag immunoblot or Gag ELISA, respectively. Asterisks indicate statistically
signiﬁcant diﬀerence from Sc siRNA (P=0.0006 for cell-associated and P<0.0001 for cell-free Gag, respectively). (C) Cell-free Gag production
measured by Gag ELISA (n=3). Asterisks indicate statistically signiﬁcant diﬀerence from Sc siRNA at indicated time point (P 0.0001).
1690 Nucleic Acids Research, 2010, Vol.38, No. 5Immunoblotting veriﬁed RHA down-regulation (Figure
5A), and antisera to a-Tubulin and Histone H1 veriﬁed
eﬀective nucleus and cytoplasm fractionation (Figure 5B).
The gag and b-actin RNA levels were neither reduced by
RHA down-regulation nor by the cytoplasmic accumula-
tion of gag RNA (Figure 5C). Similar to the results of
Figure 4, Gag IP on these samples determined that
RHA down-regulation reduced de novo Gag protein syn-
thesis but did not aﬀect Actin synthesis (data not shown).
Given the similar levels of HIV-1 gag mRNA, the results
indicate that RHA down-regulation reduces the
translational eﬃciency of HIV-1 gag RNA. As
summarized in Figure 5C, gag translation eﬃciency was
reduced by a factor of 4.
Next, we evaluated whether exogenous expression of
siRNA-resistant FLAG-RHA is suﬃcient to rescue Gag
protein synthesis. HEK 293 cells were treated with
siRNAs and immunoblot determined that RHA was
down-regulated (data not shown). These cells were
transfected for 48h with siRNA-resistant FL-RHA and
HIV-1
NL4–3 and second treatment of siRNA, and then
subjected to IP. RHA immunoblot veriﬁed RHA
down-regulation and also detected the FL-RHA
(Figure 6A, bottom). FLAG immunoblot veriﬁed expres-
sion of siRNA-resistant FL-RHA and Actin immunoblot
controlled for protein loading (Figure 6A, bottom).
Similar to results of Figure 4, Gag IP indicated that
RHA down-regulation severely impaired de novo Gag
protein synthesis (Figure 6A, top). Furthermore, expres-
sion of the siRNA-resistant FL-RHA rescued Gag protein
synthesis (Figure 6A, top). Actin protein synthesis was not
aﬀected by RHA down-regulation or FL-RHA expres-
sion, consistent with previous results (2). To examine the
role for the ATP-dependent helicase (22), we evaluated
rescue by siRNA-resistant FL-RHA bearing K417R
point mutation previously shown to eliminate ATP hydro-
lysis (11,22). FLAG immunoblot veriﬁed expression of
K417R (Figure 6B, bottom). Gag IP determined that
the K417R mutant did not rescue Gag protein synthesis,
suggesting that the ATP-dependent helicase activity is
necessary for eﬃcient translation of HIV-1 gag
(Figure 6B, top). As expected, Actin synthesis was not
aﬀected by expression of K417R. The results
demonstrated that RHA is necessary for eﬃcient transla-
tion of gag RNA and the ATP-dependent helicase domain
is involved.
Figure 4. RHA is necessary for eﬃcient translation of HIV-1 gag
RNA. HEK 293 cells were transfected consecutively with non-silencing
(Sc) or RHA siRNAs (RHA) and HIV-1
NL4–3 for 48h, labeled for 1h
with [
35S]-cysteine/methionine and immunoprecipitation was performed
in triplicate. Graph summarizes densitometry of [
35S]-labeled Gag and
b-Actin protein. Asterisks indicate statistically signiﬁcant diﬀerence
from Sc siRNA control (P=0.002).
Figure 5. RHA down-regulation does not aﬀect cytoplasmic accumu-
lation of HIV-1 gag RNA. HEK 293 cells were transfected
consecutively with non-silencing (Sc) or RHA siRNAs (RHA) and
HIV-1
NL4–3 for 48h and aliquots harvested for fractionation or 1h
labeling with [
35S]-cysteine/methionine. (A) Immunoblot of total cell
protein with antiserum to RHA or b-Actin. (B) Immunoblot of
nuclear or cytoplasmic extracts with Histone H1 or Tubulin
antibody. (C) RT real-time PCR measured nuclear or cytoplasmic
gag RNA and b-actin RNA. Cytoplasmic accumulation of gag RNA
relative to b-actin is expressed as percentage. Translational eﬃciency is
expressed as ratio of [
35S]-labeled Gag protein to cytoplasmic gag
RNA.
Nucleic Acids Research,2010, Vol.38, No. 5 1691RHA is not necessary for packaging of virion
RNA or LysRS
Next, we examined virions produced from cells treated
with RHA siRNA or non-silencing control siRNA. As
described in the last section, RHA was down-regulated,
veriﬁed by immunoblot, HIV-1
NL4–3 was transfected with
a second treatment of siRNA and after 48h, progeny
virions were harvested by centrifugation and virion-
associated RNA was quantiﬁed by RT-real-time PCR.
Immunoblotting veriﬁed down-regulation of RHA but
no change in Actin or cell-associated Lys-tRNA
synthetase (LysRS) (Figure 7A). However, HIV-1 Gag
p55 and the processed forms of the Gag precursor
protein p37 and p24 were reduced by RHA
down-regulation. High exposure of the Gag immunoblot
revealed that Gag-Pol polyprotein p160 is also reduced
(right panel). As expected RT immunoblot detected
similar reduction in RT p66, which is proteolytic pro-
cessed from Gag-Pol p160. Vif, Rev and Nef immunoblot
revealed concordant reduction in these virus proteins, sug-
gesting that RHA is important for translation of
genome-length, single-spliced and double-spliced mRNA.
Next, equivalent quantities of virions were subjected to
immunoblot (Figure 7B) and extraction of virion-
associated RNA (5ng Gag for immunoblot and 25ng
Gag for RNA extraction as measured by Gag ELISA).
Gag immunoblot veriﬁed equivalent virion loading
(Figure 7B, bottom panel). As expected, virions
produced from cells treated with RHA siRNA are deﬁ-
cient in RHA (Figure 7B, top panel). However they are
not deﬁcient in cellular cofactor LysRS (23) nor processed
RT (Figure 7B, middle panels). RT-real-time PCR with
Figure 6. ATPase domain of RHA is necessary for eﬃcient translation of HIV-1 gag RNA. HEK 293 cells were transfected consecutively with
non-silencing (Sc) or RHA siRNAs (RHA) and HIV-1
NL4–3 for 48h. Cells were labeled with [
35S]-cysteine/methionine for 1h for IP with Gag and
b-Actin antibody. (A) Evaluation of rescue by siRNA-resistant FLAG-RHA by IP (top panel). Immunoblot of total cell protein with indicated
antiserum veriﬁed RHA down-regulation, expression of siRNA-resistant FLAG-RHA and equal protein loading, respectively (bottom panel).
(B) Evaluation of rescue by siRNA-resistant FLAG-RHA K417R by IP (top panel). Immunoblot of total cell protein with indicated antiserum
veriﬁed RHA down-regulation, expression of siRNA-resistant FLAG-RHA K417R and equal protein loading, respectively (bottom panel).
1692 Nucleic Acids Research, 2010, Vol.38, No. 5gag primers detected similar amounts of virion-associated
RNA (Figure 7C). In this particular experiment,
RT-real-time PCR on total cellular RNA detected a
minor reduction in cell-associated gag RNA, Figure 7C.
The results indicate that viral RNA packaging eﬃciency
was not reduced by RHA down-regulation. In sum,
analysis of HIV-1
NL4–3 demonstrated that RHA
down-regulation reduces the eﬃciency of HIV-1 RNA
translation. However, virion associated LysRS and viral
RNA are not reduced, suggesting that RHA is not neces-
sary for their packaging into RHA-deﬁcient particles.
RHA is important for HIV-1 infectivity on primary cells
To examine the eﬀect of RHA down-regulation on HIV-1
infectivity, equivalent cell-free virion preparations were
used for infection of human PBMCs or a HeLa-based
Luciferase reporter cell line, TZM-bl integrated with
HIV-1 LTRluc reporter gene (13–16). Gag ELISA was
performed on the supernatant medium from producer
cells treated withRHA siRNA or Sc siRNA, and infections
were performed with 2ng Gag aliquots of virions deﬁcient
in RHA or containing RHA. Virus growth on PBMC in
triplicate experiments determined that RHA-deﬁcient
virions exhibit reduced Gag production in PBMC
(Figure 8). Reduced virus growth was observed at days 6,
9 and 12, indicating virus replication is impaired
(P<0.0005, 0.0008, 0.0174, respectively, Figure 8A).
Similarly, virus infectivity on TZM-bl cells was reduced
and expression of siRNA-resistant RHA was suﬃcient to
rescue HIV-1 infectivity (Figure 8B). The results demon-
strate that RHA down-regulation impaired the infectivity
of progeny virions. In conclusion, RHA plays two critical
roles in the virus producer cell: (i) RHA is necessary for
eﬃcient HIV-1 translation; (ii) RHA assembled into HIV-1
virions promotes infectivity on primary human cells.
Figure 7. RHA down-regulation reduces virus protein but not HIV-1
RNA packaging. HEK 293 cells were transfected consecutively with
scrambled (Sc) or RHA (RHA) siRNAs and HIV-1
NL4–3 provirus
and cellular protein and RNA were isolated. Gag p24 ELISA on
cell-free medium was performed. (A) Immunoblot of total cell protein
(10mg) with antiserum to Gag, RHA, LysRS, Vif, Nef, Rev or b-Actin.
(B) Immunoblot of virion preparation (equivalent to 5ng of p24) with
antiserum to RHA, LysRS, RT, Gag. (C) RT-real-time PCR deter-
mined copy number.
aGag copy number in virion preparation equiva-
lent to 25ng of p24.
bCellular gag RNA copy number standardized to
b-actin RNA.
Figure 8. RHA down-regulation reduces infectivity of progeny HIV-1.
(A) HEK 293 cells were transfected with scrambled (Sc) or RHA
(RHA) siRNAs, and then second dose of siRNA and HIV-1
NL4–3 for
48h. Cell-free virus equivalent to 2ng Gag was used to infect activated
PBMCs. Virus growth on PBMC was measured by Gag ELISA (n=3).
Asterisks indicate statistically signiﬁcant diﬀerence from Sc siRNA
control was observed at day 6, 9 and 12 (P 0.0005, 0.0008, 0.0174).
(B) HEK 293 cells were transfected with Sc or RHA siRNAs, and then
second dose of siRNA with either empty vector or siRNA-resistant
FLAG-RHA and HIV-1
NL4–3. Cell-free virus equivalent to 2ng Gag
was used to infect TZM-bl cells and luciferase activity determined at
48h (n=3).
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RHA is an important host factor
This report determined that RHA is necessary for two
aspects of HIV-1 biology: RHA present in the infected
cell facilitates eﬃcient translation of viral mRNA and
RHA assembled into virus particles promotes infectivity
of progeny virions. The virions are not deﬁcient in viral
RNA, processed RT, nor the cellular cofactor LysRS. The
results open the new issue of the possible interrelationship
of RHA promoting viral mRNA translation and produc-
tion of infectious virions.
First, the results demonstrated that translation of
HIV-1 gag mRNA is reliant on the ATP-dependent
helicase activity of RHA. A straightforward model is
that RHA interaction promotes RNP rearrangement to
open the complex 50 UTR to eﬃcient ribosome scanning
(Figure 9). We invoke ribosome scanning model instead of
an internal ribosome entry site (IRES)-related mechanism
because RHA has been shown to promote cap-dependent,
but not cap-independent translation (5) and because the
retroviral PCEs do not substitute for IRES in a bicistronic
reporter RNA (5). We speculate that all HIV-1 transcripts
require RHA for eﬃcient translation for two reasons:
(i) all HIV-1 transcripts contain the similar highly
complex 50 UTR (1), which includes the RU5 region
that conveys PCE reporter activity and interacts with
RHA (Figure 2) and was previously shown to be suﬃcient
for RHA-dependent PCE activity (5); (ii) Vif, Rev and Nef
protein levels are reduced by RHA down-regulation, con-
sistent with translation down-regulation (Figure 7). These
observations open new questions. First, what features
of HIV-1 RU5 and possibly distal sequences are suﬃ-
cient for the speciﬁc interaction with RHA. Second, is
the ATP-dependent helicase activity of RHA necessary
to promote virus infectivity. Attractive speculation is
that helicase-dependent rearrangement of the 50 UTR
involving RHA changes the activity of other cis-acting
replication sequences in the 50 UTR, including the
packaging signal.
A simple model invokes an inverse relationship between
translation and packaging eﬃciency. Herein RHA
neutralizes structural features of the 50 UTR to promote
eﬃcient ribosome scanning. However, the structural
Figure 9. Model summarizing that DExD/H proteins contribute to many steps in retroviral posttranscriptional gene expression and coordination of
virus assembly. Nuclear export of HIV-1 Rev/Rev responsive element (RRE)-dependent HIV-1 RNA requires DDX3 with CRM1 nuclear export
receptor (27). Alternatively, the nuclear export ribonucleoprotein (RNP) of completely spliced viral RNA involves superfamily members RBM15 and
DBP5 and NXF1 nuclear export receptor (28,29). Eﬃcient viral translation requires DHX9/RNA helicase A [herein and (5)]. RNA helicase A
recognizes structural features of virus 50 RNA terminus and possibly distal structures, and facilitates eﬃcient protein synthesis in an ATP-dependent
manner (2). RNA helicase A also assembles into virions and supports virus infectivity, perhaps by promoting rearrangement of the viral RNP for
reverse transcription or by carrying in a host cofactor (12). DDX24 promotes packaging of HIV-1 RNA (30).
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RNA packaging signal. The predicted outcome is
reduced virion RNA content that engenders lower virion
infectivity. Unexpectedly, the prediction of less viral RNA
content was not validated by RHA down-regulation
assays with highly sensitive quantitative RT-real-time
PCR (Figure 7) or RNase protection assay (12); viral
RNA packaging was not impaired. A caveat to the exper-
imental approaches is the down-regulation of Gag protein
synthesis changes the intracellular ratio of assembling
virions to viral RNA. The reduction in Gag is not in pro-
portion to viral RNA level; the increased steady-state
virion precursor RNA and may eliminate the need for
eﬃciency in the RNA assembly process, and erase detec-
tion of a packaging phenotype. In sum, alternative exper-
iments are needed to measure whether or not the
ATP-dependent helicase activity aﬀects the activity of
the packaging signal, and possibly other cis-acting repli-
cation sequences in the 50 UTR.
Particle-associated RHA may be important for
infectivity by aﬀecting the eﬃciency of reverse transcrip-
tion, as ﬁrst suggested by Liang (12). In our report,
immunoblots veriﬁed that RHA down-regulation did not
reduce processed RT in the RHA-deﬁcient particles
(Figure 7). Possibly, RHA helicase activity may be neces-
sary for proper conformation of the primer binding site,
accessibility to tRNA, or primer annealing. Our
immunoblots demonstrated that RHA down-regulation
does not eliminate packaging of the LysRS, which is
involved in tRNA packaging (23). Another option is
RHA supports virus infectivity independently of helicase
activity; in this model RHA acts as a scaﬀold for accessory
host protein or RNA cofactor (Figure 9).
RHA may also operate a mechanistic link between
HIV-1 RNA traﬃcking and infectious virion assembly.
Results with Ty3 show that traﬃcking the viral
RNP through processing bodies promotes assembly of
virus-like particles (24) and yeast strains deﬁcient in
DhhP1, a DEAD box protein that is a central protein
for translation repression and targeting mRNAs to
these RNA storage granules, are deﬁcient in retrotran-
sposition (24,25). Likewise, RHA traﬃcking between
polysomes (2,5) and stress granules (Bolinger and
Boris-Lawrie, unpublished results) may coordinate viral
RNA fates as mRNA template and translationally
inactive virion precursor RNA that is assembled
into nascent particles (Figure 9). This notion is supported
by observations that translation of cytoplasmic HIV-1
RNA is not necessary for its assembly into progeny
virions and may be recruited in a translationally repressed
form (26).
The role of yeast DhhP1 and metazoan RHA supports
the growing realization that DExD/H proteins contribute
to many, if not all steps in retroviral posttranscriptional
gene expression and coordination of virus assembly.
As summarized in Figure 9, DExD/H superfamily
members DDX3, RBM15 and DBP5 are components of
ribonucleoprotein (RNP) complexes that promote nuclear
export of viral RNA (27–29). Superfamily members
DhhP1, RHA and DDX24 facilitate viral RNA traﬃcking
and coordination of virus assembly (12,24,30). In
conclusion, further study of RHA in retroviruses is
expected to illuminate the poorly understood issue of
how the translation and assembly processes are
coordinated. Historically the virus-host interactions that
contribute to coordination of the translation and assembly
processes have been of great interest (31).
RHA response element is conserved across Retroviridae
PCE reporter assays determined that the RU5 region of
the HIV-1 50 LTR and the HTLV-1 LTR facilitate
HIV-1-based reporter mRNA translation. These new
ﬁndings suggest that previous studies of reporter
constructs containing RU5 sequences may be explained
by RHA translational stimulation. In particular, reports
of increased HIV-1 LTR-luciferase activity (9,32) and
virion protein production by RHA overexpression (10)
may be attributed to increased translation. Likewise,
HTLV-1 RU5 has been used in retrovirus vectors to
increase translation eﬃciency (33,34) and we speculate
that this activity is attributable to increased
RHA-dependent PCE activity. SNV PCE has been
employed in HIV-1 based lentivirus vector to increase
transgene translation (35).
The identiﬁcation of PCE activity in the RU5 region of
HTLV-1 and HIV-1 identiﬁes conservation across six of
the seven genera of the Retroviridae (3–5,36). Future
experiments with 50 LTR sequences from the Epsilon
genus are necessary to address possible conservation of
PCE activity across all genera of this virus family. In con-
clusion, the identiﬁcation of RHA-dependent PCE activity
in cellular junD RNA and in six of seven genera of
Retroviridae suggests conservation of this translational
control mechanism among vertebrates, and convergent
evolution of Retroviridae to utilize this host mechanism.
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